Antithrombotic Therapy During Percutaneous Coronary Intervention

This publication has 117 references indexed in Scilit:

• Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study
  American Heart Journal, 2003
• A randomized trial assessing the effect of coumarins started before coronary angioplasty on restenosis: Results of the 6-month angiographic substudy of the Balloon Angioplasty and Anticoagulation Study (BAAS)
  American Heart Journal, 2003
• Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary revascularization using integrilin and single bolus enoxaparin study
  JACC, 2003
• Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2242 patients
  American Heart Journal, 1996
• Effects of endoluminal coronary stents on the frequency of coronary artery bypass grafting after unsuccessful percutaneous transluminal coronary revascularization
  The American Journal of Cardiology, 1996
• Multi-Hospital Eastern Atlantic Restenosis Trial II: A placebo-controlled trial of thromboxane blockade in the prevention of restenosis following coronary angioplasty
  American Heart Journal, 1991
• Effects of low-dose aspirin on restenosis after coronary angioplasty
  The American Journal of Cardiology, 1991
• Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplasty
  The American Journal of Cardiology, 1990
• Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty
  American Heart Journal, 1989
• Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
  New England Journal of Medicine, 1988